75%Confidence
0Views
FDASource
2026-03-07Date
Summary
AmerisourceBergen faces oxycodone blister pack defects that could lead to medication errors and regulatory attention amid the opioid crisis. This packaging issue may trigger supply chain reviews and increased scrutiny on controlled substance distribution practices.
Actionable: Monitor AmerisourceBergen's regulatory compliance metrics and consider temporary reduction in pharmaceutical distribution holdings.
AI Confidence: 75%
Data Points
firmAmerisource Health Services LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productOxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now